KRYS - Krystal Biotech GAAP EPS of -$1.10 misses by $0.07 August, 08 2022 08:39 AM Krystal Biotech Inc. Krystal Biotech press release ( NASDAQ: KRYS ): Q2 GAAP EPS of -$1.10 misses by $0.07 . Strong balance sheet, closing the quarter with $438.5 million in cash, cash equivalents and investments. For further details see: Krystal Biotech GAAP EPS of -$1.10 misses by $0.07